SCHEMBL7462972

SCHEMBL7462972

NC(CC(=O)NO)NC(=O)c1ccccc1

nearest known ligand 0.50

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
HDAC1 Q13547 6/20 0.50
HDAC3 O15379 5/20 0.50
HDAC7 Q8WUI4 5/20 0.50
HDAC2 Q92769 5/20 0.50
HDAC8 Q9BY41 5/20 0.50
HDAC6 Q9UBN7 5/20 0.50
NCOR2 Q9Y618 2/20 0.50
CA12 O43570 1/20 0.50
CA1 P00915 1/20 0.50
IDO1 P14902 1/20 0.50
ALOX15 P16050 1/20 0.50
CA9 Q16790 1/20 0.50
HSD17B10 Q99714 1/20 0.50
SLC1A2 P43004 1/20 0.50
HDAC4 P56524 4/20 0.46
HDAC10 Q969S8 4/20 0.46
HDAC11 Q96DB2 4/20 0.46
HDAC9 Q9UKV0 4/20 0.46
HDAC5 Q9UQL6 4/20 0.46
CTRB1 P17538 3/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2234114 0.84 SLC1A2 (0.54) HDAC1HDAC3HDAC7HDAC2HDAC8
SCHEMBL7471469 0.82 HDAC1 (0.58) HDAC1HDAC3HDAC2HDAC8HDAC6
SCHEMBL7417166 0.79 MEN1 (0.64) HDAC1HDAC3HDAC7HDAC2HDAC8
SCHEMBL12515063 0.78 HDAC3 (0.47) HDAC1HDAC3HDAC7HDAC2HDAC8
SCHEMBL13175274 0.74 HDAC1 (0.66) HDAC1HDAC3HDAC7HDAC2HDAC8
SCHEMBL8090912 0.74 HDAC1 (0.66) HDAC1HDAC3HDAC7HDAC2HDAC8
SCHEMBL27529872 0.74 SLC1A2 (0.63) HDAC1HDAC3HDAC7HDAC2HDAC8
SCHEMBL12262967 0.74 SLC1A2 (0.63) HDAC1HDAC3HDAC7HDAC2HDAC8
SCHEMBL2840189 0.72 LMNA (0.59) HDAC1HDAC3HDAC7HDAC2HDAC8
SCHEMBL7417076 0.71 NPC1 (0.51) HDAC1HDAC3HDAC7HDAC2HDAC8

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6218389-B1 FOR THERAPY AND PROPHYLAXIS OF ARTHRITIS, CANCER, CARDIOVASCULAR DISORDERS; SKIN DISORDERS; OCULAR DISORDERS; INFLAMMATION AND GUM DISEASES, MULTIPLE SCLEROSIS, CACHEXIA, PREVENTING LOOSENING OF PROSTHETIC DEVICES THE PROCTER & GAMBLE CO. 2001-04-17 US disclosed
EP-1009737-A2 SULFONYLAMINO SUBSTITUTED HYDROXAMIC ACID DERIVATIVES AS METALLOPROTEASE INHIBITORS THE PROCTER & GAMBLE COMPANY (US) 2000-06-21 EP disclosed
WO-1999006340-A2 SULFONYLAMINO SUBSTITUTED HYDROXAMIC ACID DERIVATIVES AS METALLOPROTEASE INHIBITORS THE PROCTER & GAMBLE COMPANY (US) 1999-02-11 WO disclosed